Nov 07, 2017 4:20pm EST SCYNEXIS Reports Third Quarter 2017 Financial Results and Provides Company Update
Oct 05, 2017 8:30am EDT SCYNEXIS Presents New Data Further Supporting SCY-078 as a Potential Treatment for Aspergillus and Candida Infections at IDWeek 2017
Aug 15, 2017 8:00am EDT “THINK FUNGUS” - SCYNEXIS Recognizes Fungal Disease Awareness Week Sponsored by the Centers for Disease Control and Prevention (CDC)
Aug 14, 2017 8:00am EDT SCYNEXIS Presents New Data Supporting Oral SCY-078 for the Clinical Treatment of Vulvovaginal Candidiasis Infections at the 2017 IDSOG Annual Meeting
Aug 08, 2017 4:25pm EDT SCYNEXIS Reports Second Quarter 2017 Financial Results and Provides Company Update
